Wu et al. [64] reported that METTL3, METTL14, FTO, and ALKBH5 are upregulated and WTAP is downregulated in luminal breast cancer patients, while the expression level of FTO is significantly decreased in HER2-positive breast cancer. This evidence concerns the gene FTO and breast carcinoma.